Assessing the impact of haemodynamic monitoring with CardioMEMS on heart failure patients: a cost–benefit analysis
Aims: The objective of this study was to perform a cost–benefit analysis of the CardioMEMS HF System (Abbott Laboratories, Abbott Park, IL, USA) in a heart failure (HF) clinic in Spain by evaluating the real-time remote monitoring of pulmonary artery pressures, which has been shown to reduce HF-rela...
| Autores: | , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | España |
| Recursos: | Universitat Pompeu Fabra |
| Repositorio: | Repositorio Digital de la UPF |
| OAI Identifier: | oai:repositori.upf.edu:10230/61386 |
| Acesso em linha: | http://hdl.handle.net/10230/61386 http://dx.doi.org/10.1002/ehf2.14698 |
| Access Level: | acceso abierto |
| Palavra-chave: | Cost–benefit Pulmonary pressure sensor Monitoring Hospitalizations Heart failure |
| id |
ES_4fdf01bb4b202dc9d0bdd3347c6bb391 |
|---|---|
| oai_identifier_str |
oai:repositori.upf.edu:10230/61386 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Assessing the impact of haemodynamic monitoring with CardioMEMS on heart failure patients: a cost–benefit analysisCodina, PauVicente Gómez, José ÁngelHernández Guillamet, GuillemRicou Ríos, LauraCarrete, AndreaVilalta, VictoriaEstrada Cuxart, OriolAra del Rey, JordiLupón, JosepBayés-Genís, AntoniLópez Seguí, Francesc, 1991-Cost–benefitPulmonary pressure sensorMonitoringHospitalizationsHeart failureAims: The objective of this study was to perform a cost–benefit analysis of the CardioMEMS HF System (Abbott Laboratories, Abbott Park, IL, USA) in a heart failure (HF) clinic in Spain by evaluating the real-time remote monitoring of pulmonary artery pressures, which has been shown to reduce HF-related hospitalizations and improve the quality of life for selected HF patients. Particularly, the study aimed to determine the value of CardioMEMS in Southern Europe, where healthcare costs are significantly lower and its effectiveness remains uncertain. Methods and results: This single-centre study enrolled all consecutive HF patients (N = 43) who had been implanted with a pulmonary artery pressure sensor (CardioMEMS HF System); 48.8% were females, aged 75.5 ± 7.0 years, with both reduced and preserved left ventricular ejection fraction; 67.4% of them were in New York Heart Association Class III. The number of HF hospitalizations in the year before and the year after the sensor implantation was compared. Quality-adjusted life years gained based on a literature review of previous studies were calculated. The rate of HF hospitalizations was significantly lower at 1 year compared with the year before CardioMEMS implantation (0.25 vs. 1.10 events/patient-year, hazard ratio 0.22, P = 0.001). At the end of the first year, the usual management outperformed the CardioMEMS HF System. By the end of the second year, the CardioMEMS system is estimated to reduce costs compared with usual management (net benefits of €346). Conclusions: Based on the results, we suggest that remote monitoring of pulmonary artery pressure with the CardioMEMS HF System represents a midterm and long-term efficient strategy in a healthcare setting in Southern Europe.Wiley202420242024info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/61386http://dx.doi.org/10.1002/ehf2.14698reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésESC Heart Failure. 2024 Aug;11(4):1955-62© 2024 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.http://creativecommons.org/licenses/by-nc/4.0/info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/613862026-06-12T07:21:37Z |
| dc.title.none.fl_str_mv |
Assessing the impact of haemodynamic monitoring with CardioMEMS on heart failure patients: a cost–benefit analysis |
| title |
Assessing the impact of haemodynamic monitoring with CardioMEMS on heart failure patients: a cost–benefit analysis |
| spellingShingle |
Assessing the impact of haemodynamic monitoring with CardioMEMS on heart failure patients: a cost–benefit analysis Codina, Pau Cost–benefit Pulmonary pressure sensor Monitoring Hospitalizations Heart failure |
| title_short |
Assessing the impact of haemodynamic monitoring with CardioMEMS on heart failure patients: a cost–benefit analysis |
| title_full |
Assessing the impact of haemodynamic monitoring with CardioMEMS on heart failure patients: a cost–benefit analysis |
| title_fullStr |
Assessing the impact of haemodynamic monitoring with CardioMEMS on heart failure patients: a cost–benefit analysis |
| title_full_unstemmed |
Assessing the impact of haemodynamic monitoring with CardioMEMS on heart failure patients: a cost–benefit analysis |
| title_sort |
Assessing the impact of haemodynamic monitoring with CardioMEMS on heart failure patients: a cost–benefit analysis |
| dc.creator.none.fl_str_mv |
Codina, Pau Vicente Gómez, José Ángel Hernández Guillamet, Guillem Ricou Ríos, Laura Carrete, Andrea Vilalta, Victoria Estrada Cuxart, Oriol Ara del Rey, Jordi Lupón, Josep Bayés-Genís, Antoni López Seguí, Francesc, 1991- |
| author |
Codina, Pau |
| author_facet |
Codina, Pau Vicente Gómez, José Ángel Hernández Guillamet, Guillem Ricou Ríos, Laura Carrete, Andrea Vilalta, Victoria Estrada Cuxart, Oriol Ara del Rey, Jordi Lupón, Josep Bayés-Genís, Antoni López Seguí, Francesc, 1991- |
| author_role |
author |
| author2 |
Vicente Gómez, José Ángel Hernández Guillamet, Guillem Ricou Ríos, Laura Carrete, Andrea Vilalta, Victoria Estrada Cuxart, Oriol Ara del Rey, Jordi Lupón, Josep Bayés-Genís, Antoni López Seguí, Francesc, 1991- |
| author2_role |
author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Cost–benefit Pulmonary pressure sensor Monitoring Hospitalizations Heart failure |
| topic |
Cost–benefit Pulmonary pressure sensor Monitoring Hospitalizations Heart failure |
| description |
Aims: The objective of this study was to perform a cost–benefit analysis of the CardioMEMS HF System (Abbott Laboratories, Abbott Park, IL, USA) in a heart failure (HF) clinic in Spain by evaluating the real-time remote monitoring of pulmonary artery pressures, which has been shown to reduce HF-related hospitalizations and improve the quality of life for selected HF patients. Particularly, the study aimed to determine the value of CardioMEMS in Southern Europe, where healthcare costs are significantly lower and its effectiveness remains uncertain. Methods and results: This single-centre study enrolled all consecutive HF patients (N = 43) who had been implanted with a pulmonary artery pressure sensor (CardioMEMS HF System); 48.8% were females, aged 75.5 ± 7.0 years, with both reduced and preserved left ventricular ejection fraction; 67.4% of them were in New York Heart Association Class III. The number of HF hospitalizations in the year before and the year after the sensor implantation was compared. Quality-adjusted life years gained based on a literature review of previous studies were calculated. The rate of HF hospitalizations was significantly lower at 1 year compared with the year before CardioMEMS implantation (0.25 vs. 1.10 events/patient-year, hazard ratio 0.22, P = 0.001). At the end of the first year, the usual management outperformed the CardioMEMS HF System. By the end of the second year, the CardioMEMS system is estimated to reduce costs compared with usual management (net benefits of €346). Conclusions: Based on the results, we suggest that remote monitoring of pulmonary artery pressure with the CardioMEMS HF System represents a midterm and long-term efficient strategy in a healthcare setting in Southern Europe. |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024 2024 2024 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10230/61386 http://dx.doi.org/10.1002/ehf2.14698 |
| url |
http://hdl.handle.net/10230/61386 http://dx.doi.org/10.1002/ehf2.14698 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
ESC Heart Failure. 2024 Aug;11(4):1955-62 |
| dc.rights.none.fl_str_mv |
http://creativecommons.org/licenses/by-nc/4.0/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Wiley |
| publisher.none.fl_str_mv |
Wiley |
| dc.source.none.fl_str_mv |
reponame:Repositorio Digital de la UPF instname:Universitat Pompeu Fabra |
| instname_str |
Universitat Pompeu Fabra |
| reponame_str |
Repositorio Digital de la UPF |
| collection |
Repositorio Digital de la UPF |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869407846392659968 |
| score |
15,811543 |